Hsbc Holdings PLC Forte Biosciences, Inc. Transaction History
Hsbc Holdings PLC
- $160 Billion
- Q2 2024
A detailed history of Hsbc Holdings PLC transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 10,745 shares of FBRX stock, worth $62,321. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,745
Previous 10,745
-0.0%
Holding current value
$62,321
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding FBRX
# of Institutions
33Shares Held
19MCall Options Held
3.1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$21 Million0.49% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$18.9 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$17.3 Million0.05% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$11.8 Million1.15% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$10.7 Million0.0% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $118M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.